Women's Health Archive

Women officially reach menopause a year after periods end. Any vaginal bleeding after menopause should be evaluated. Bleeding can come from vaginal dryness or atrophy, medication side effects, various infections, endometrial thickening, or cancer.

The FDA added a boxed warning in December 2024 to fezolinetant (Veozah), a nonhormonal drug that reduces hot flashes and night sweats in menopausal women. The drug may cause rare but serious liver injury.

An estimated six in 10 women will at some point experience symptoms from pelvic floor weakness. Risk factors include pregnancy (especially with vaginal delivery), chronic constipation, family history, smoking, aging, menopause, obesity, chronic coughing, and occupations involving heavy lifting. Women with pelvic floor weakness may experience signs such as leaking urine, having trouble using a tampon, being unable to fully empty their bladder or rectum, and feeling a bulge in their vagina.

Although a clinical trial showed daily aspirin use didn't help women with breast cancer avoid recurrence or improve survival, other evidence-backed measures might. Exercise, weight control, and a healthy diet are linked with lower recurrence and longer survival, but alcohol use, smoking, and supplement use are not. While it's not always clear how lifestyle approaches help lower the odds of recurrence or death from breast cancer, healthy measures can improve women's ability to keep other conditions at bay or manage them more effectively.

As estrogen levels drop, women's bodies store more fat around the abdomen, fueling a weight shift to the belly. Women can counter this by ramping up protein intake and doing strength training to maintain muscle mass and metabolism.

Vaginal moisturizer and lubricant both combat vaginal dryness, but they're not the same. Vaginal moisturizers are absorbed into vaginal tissue, while lubricants remain on the surface. Women should speak to their doctor if vaginal dryness persists.

Pap tests, the mainstay screening method to detect cervical cancer, are uncomfortable for some women. In mid-2024, the FDA approved a new self-swab test that can detect human papillomavirus, which causes most cases of cervical cancer. The self-swab test collects cells from the vaginal wall instead of the cervix. Clinicians guide women on how to perform the test in a doctor's office. The self-swab method offers women several benefits, including comfort, accuracy, and potentially greater access to screening.